Annual CFF
$1.85 M
-$2.13 M-53.55%
June 1, 2024
Summary
- As of February 7, 2025, GENE annual cash flow from financing activities is $1.85 million, with the most recent change of -$2.13 million (-53.55%) on June 1, 2024.
- During the last 3 years, GENE annual CFF has fallen by -$8.37 million (-81.89%).
- GENE annual CFF is now -90.33% below its all-time high of $19.14 million, reached on June 30, 2015.
Performance
GENE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1.57 M
+$1.68 M+1477.37%
June 1, 2024
Summary
- As of February 7, 2025, GENE quarterly cash flow from financing activities is $1.57 million, with the most recent change of +$1.68 million (+1477.37%) on June 1, 2024.
- Over the past year, GENE quarterly CFF has dropped by -$2.00 million (-56.04%).
- GENE quarterly CFF is now -82.49% below its all-time high of $8.97 million, reached on March 1, 2005.
Performance
GENE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$1.46 M
-$2.00 M-57.89%
June 1, 2024
Summary
- As of February 7, 2025, GENE TTM cash flow from financing activities is $1.46 million, with the most recent change of -$2.00 million (-57.89%) on June 1, 2024.
- Over the past year, GENE TTM CFF has dropped by -$2.01 million (-57.94%).
- GENE TTM CFF is now -83.76% below its all-time high of $8.97 million, reached on March 1, 2005.
Performance
GENE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GENE Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -53.5% | -56.0% | -57.9% |
| 3 y3 years | -81.9% | -56.0% | -57.9% |
| 5 y5 years | -17.3% | -56.0% | -57.9% |
GENE Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -81.9% | +1014.2% | -56.0% | +875.8% | -57.9% | +352.4% |
| 5 y | 5-year | -85.0% | +1014.2% | -66.8% | +377.5% | -69.2% | +352.4% |
| alltime | all time | -90.3% | +490.3% | -82.5% | +377.5% | -83.8% | +352.4% |
Genetic Technologies Limited Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | $1.85 M(-53.5%) | $1.57 M(-1477.4%) | $1.46 M(-57.9%) |
| Dec 2023 | - | -$114.00 K(-103.2%) | $3.46 M(-0.1%) |
| Jun 2023 | $3.98 M(-2067.9%) | $3.57 M(-3365.0%) | $3.46 M(-1210.5%) |
| Dec 2022 | - | -$109.40 K(-45.9%) | -$311.80 K(+46.0%) |
| Jun 2022 | -$202.40 K(-102.0%) | -$202.40 K(+1707.1%) | -$213.60 K(-63.0%) |
| Dec 2021 | - | -$11.20 K(-98.0%) | -$577.00 K(-113.9%) |
| Jun 2021 | $10.22 M(-17.1%) | -$565.80 K(-112.0%) | $4.16 M(-12.0%) |
| Dec 2020 | - | $4.73 M | $4.73 M |
| Jun 2020 | $12.32 M(+451.1%) | - | - |
| Jun 2019 | $2.24 M(<-9900.0%) | - | - |
| Jun 2018 | -$7700.00(-100.1%) | - | - |
| Jun 2017 | $5.36 M(<-9900.0%) | - | - |
| Jun 2016 | -$1200.00(-100.0%) | - | - |
| Jun 2015 | $19.14 M(+74.9%) | - | - |
| Jun 2014 | $10.95 M(+2333.5%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2013 | $449.80 K(-96.0%) | - | - |
| Jun 2012 | $11.19 M(-3710.7%) | - | - |
| Jun 2011 | -$310.00 K(-144.7%) | - | - |
| Jun 2010 | $693.40 K(-582.2%) | - | - |
| Jun 2009 | -$143.80 K(-69.7%) | - | - |
| Jun 2008 | -$474.10 K(+28.9%) | - | - |
| Jun 2007 | -$367.80 K(+8.4%) | - | - |
| Jun 2006 | -$339.30 K(-103.4%) | - | - |
| Jun 2005 | $9.94 M(+39.3%) | - | - |
| Mar 2005 | - | $8.97 M | $8.97 M |
| Jun 2004 | $7.14 M(>+9900.0%) | - | - |
| Jun 2003 | $9500.00(-96.6%) | - | - |
| Jun 2002 | $276.80 K(-4358.5%) | - | - |
| Jun 2001 | -$6500.00(<-9900.0%) | - | - |
| Jun 2000 | $0.00 | - | - |
FAQ
- What is Genetic Technologies Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Genetic Technologies Limited?
- What is Genetic Technologies Limited annual CFF year-on-year change?
- What is Genetic Technologies Limited quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Genetic Technologies Limited?
- What is Genetic Technologies Limited quarterly CFF year-on-year change?
- What is Genetic Technologies Limited TTM cash flow from financing activities?
- What is the all time high TTM CFF for Genetic Technologies Limited?
- What is Genetic Technologies Limited TTM CFF year-on-year change?
What is Genetic Technologies Limited annual cash flow from financing activities?
The current annual CFF of GENE is $1.85 M
What is the all time high annual CFF for Genetic Technologies Limited?
Genetic Technologies Limited all-time high annual cash flow from financing activities is $19.14 M
What is Genetic Technologies Limited annual CFF year-on-year change?
Over the past year, GENE annual cash flow from financing activities has changed by -$2.13 M (-53.55%)
What is Genetic Technologies Limited quarterly cash flow from financing activities?
The current quarterly CFF of GENE is $1.57 M
What is the all time high quarterly CFF for Genetic Technologies Limited?
Genetic Technologies Limited all-time high quarterly cash flow from financing activities is $8.97 M
What is Genetic Technologies Limited quarterly CFF year-on-year change?
Over the past year, GENE quarterly cash flow from financing activities has changed by -$2.00 M (-56.04%)
What is Genetic Technologies Limited TTM cash flow from financing activities?
The current TTM CFF of GENE is $1.46 M
What is the all time high TTM CFF for Genetic Technologies Limited?
Genetic Technologies Limited all-time high TTM cash flow from financing activities is $8.97 M
What is Genetic Technologies Limited TTM CFF year-on-year change?
Over the past year, GENE TTM cash flow from financing activities has changed by -$2.01 M (-57.94%)